MicroRNAs (miRNAs) are short single-stranded RNAs that have a potentially important role in gene regulation. Using a quantitative real-time polymerase chain reaction assay specific to the mature miRNA, the expression level of a selected group of haematopoietic tissue-specific miRNAs was measured across a set of 30 primary adult acute myeloid leukaemia (AML) with a normal karyotype. The expression levels of each miRNA were correlated with the genome-wide mRNA expression profiles in the same leukaemias. This revealed that miR181a correlated strongly with the AML morphological sub-type and with the expression of genes previously identified through sequence analysis as potential interaction targets. Three other miRNAs, miR-10a, miR-10b and miR-196a-1, showed a clear correlation with HOX gene expression. Leukemia (2007) 21, 912-916.
Introduction
A large number of short endogenous non-coding RNAs have been identified in species as diverse as plants and mammals and have been designated 1 as microRNAs (miRNAs). These molecules are typically 19-25 nucleotides in length, evolutionarily conserved and appear to play an important role in modulating gene expression. This is because of complementarity-mediated binding to target mRNAs resulting in the repression of translation 2 or, as new evidence suggests, in the cleavage of the target transcript. [3] [4] [5] [6] [7] [8] Although many of the known human miRNA genes are located at fragile sites and genomic regions involved in cancer, including the HOX gene clusters, 9, 10 their role in the oncogenic process is not fully understood. However, several examples of an association between disrupted expression of specific miRNAs and cancer have been shown. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Moreover, Lu et al. 21 first observed distinct patterns of miRNA expression across tumour types and miRNA profiles reflecting the developmental lineage and the differentiation state of the tumour.
The development of the quantitative 'looped' real-time polymerase chain reaction (PCR) assay specific for the mature miRNA expression levels 22 has allowed us to investigate the correlation between the expression of endogenous miRNAs and global gene expression patterns of the same cancer cell in primary leukaemias. Using computational methods, we demonstrated that particular miRNA levels are correlated with gene expression profiles in primary adult acute myeloid leukaemia (AML) with a normal karyotype (NK).
Materials and methods

Sample collection
Upon informed consent, 30 AML samples were obtained from peripheral blood (PB) or bone marrow (BM) of patients in St Bartholomew's Hospital. The morphological diagnosis of leukaemia was made as described previously. 23 Only samples with a blast count greater than 60% in the PB were processed. The median age at diagnosis was 57.2 years (range 19-87); 17 were women, and according to the French American British (FAB) classification, 24 there were thirteen M1, seven M2, six M4 and four M5. (Full sample details are described in Supplementary Table S1 .)
Gene expression profiling
Total RNA was extracted from a total of 10 Â 10 6 to 20 Â 10 6 thawed cells using Trizol (Invitrogen, Carlsbad, CA, USA) purification method. U133A and U133B oligonucleotide arrays (Affymetrix) were used for the expression profile. cRNA target preparation and array hybridization were performed as described previously. 23 Bioconductor was used to calculate the level of expression for each gene (http://www.bioconductor.org/). The data were normalized by quantile normalization, as implemented in the Affymetrix package of Bioconductor. (The  normalized values of gene expression of the 30 NK-AML  samples for both U133A and U133B arrays are reported in  Supplementary Tables S2 and S3 , respectively.) All the statistical analysis was performed with the statistical language R (http:// www.R-project.org). GeneSpring 6.2 (Silicon Genetics) was used for the calculation and generation of the heat map from the hierarchical cluster analysis that was performed using as a metric Pearson's correlation.
Selection of miRNAs
Five miRNAs were selected from the Sanger miRNA Registry at http://www.sanger.ac.uk/ 25 (Table 1) : (a) miR-181a, known to be involved in haematopoietic differentiation 26 and to target HOX genes; [27] [28] [29] (b) miR-10a, miR-10b and miR-196a-1 located within the HOX clusters; 30, 31 and (c) miR-223, known to be expressed at a high level in cells of the myeloid lineage, 26, 32 used as normalization control.
Quantitative real-time PCR assay for miRNAs
MicroRNAs were quantitated by real-time PCR using TaqMan MicroRNA assay (Applied Biosystems). All the reagents for performing reverse transcription reaction and the real-time PCR assays specific to the mature miRNAs were provided as part of a collaboration agreement with Applied Biosystems (P/N: 4365409). The reverse transcription reaction (RT) and real-time PCR were carried out using the ABI Prism 7700 Sequence Detector System (Applied Biosystems). Total RNA was extracted from a total of 10 Â 10 6 to 20 Â 10 6 thawed cells using Trizol (Invitrogen) purification method. First-strand cDNA synthesis was carried out from 250 ng of total RNA in 7.5 ml of final volume containing 50 nM stem-loop primer, 1 Â RT buffer, 3.33 U/ml MultiScribe reverse transcriptase and 0.25 U/ml RNase inhibitor. The mix was incubated in a 96 well plate at 161C for 30 min, 421C for 30 min, 851C for 5 min and then held at 41C. All RT reactions including no-template controls were run in duplicate. Real-time PCR was performed using a standard TaqMan PCR protocol. The 10 ml PCRs reactions included 0.67 ml of RT product, 1 Â Universal TaqMan Master Mix and 1 Â TaqMan probe/primer mix. The reactions were incubated in a 96-well plate at 951C for 10 min followed by 40 cycles of 951C for 15 s and 601C for 1 min. All RT reactions including notemplate controls were run in triplicate. Input amount of total RNA samples was previously normalized based on the TaqMan Gene Expression Assay for human glyceraldehyde-3-phosphate dehydrogenase endogenous controls (P/N: 4310884E, Applied Biosystems) as recommended by Chen et al. 22 (data not shown). MiR-223 was used as endogenous control. Data were normalized against miR-223, uniformly expressed across the set of samples (average C t for 30 AML samples ¼ 15.08; s.d. of the average C t ¼ 0.67). The relative amount of transcript was calculated using the comparative C t method (Supplementary  Table S4 ).
Statistical analysis
Full details of the computational calculations are reported in Supplementary Information. In brief, the Pearson and Spearman correlation coefficients were calculated for each miRNA paired in turn with each gene measured in the AML genome-wide analysis. To make the findings robust to random association, the expression values of each miRNA were randomized among the AMLs and the correlation coefficients recalculated (Supplementary Figure S1 ). The randomization and recalculation of coefficient distribution was repeated 500 times with the same result (data not shown).
Results and discussion
Previous gene expression profile analysis of AML samples has shown a distinctive up-regulation of members of the HOXA and HOXB gene families in leukaemias with a normal karyotype. 23 Further studies of AMLs with a normal karyotype confirmed and extended the finding, providing evidence for the presence of two distinct groups with different HOX gene expression levels (Debernardi et al. Blood 2003; 102: 1322, abstract). Homeobox genes have been suggested to be among the most represented targets of miRNAs. 28, 33 The levels of five particular miRNAs (Table 1) were assessed using the 'looped' real-time PCR assay, specifically designed to measure quantitatively the mature product, 22 across a set of 30 normal karyotype AMLs (full sample details are described in Supplementary Table S1 ), for which the expression profile was available. The miRNAs were either located within the HOX clusters (miR-10a, miR-10b and miR-196a-1) or known to target homeobox genes [27] [28] [29] 34 and to be involved in haematopoietic development (miR-181a and miR-223).
26 MiR-223, uniformly expressed across the set of samples, was used to normalize the data. The miRNA assay, which was performed in triplicate, reproducibly detected expression for mir-181a, miR-10a, miR-10b and miR-196a-1.
(The detailed values are reported in Supplementary Table S4.) We wished to determine whether the expression of an individual miRNA could be correlated, either negatively or positively, with the expression of any particular gene or group of genes across the set of 30 AMLs. Hence, both the Pearson and Spearman correlation coefficients were calculated for each miRNA paired, in turn, with each of the 45 000 probe sets on the U133 set expression arrays (Affymetrix), representing nearly 39 000 transcripts. To exclude possible chance associations, the expression values of each miRNA were randomized among the samples and the correlation coefficients recalculated. The distribution of correlation coefficients derived from randomized data was Gaussian and more restricted in range than the actual data (Supplementary Figure S1) . The heavier tails in the experimental distribution indicated that a significant number of genes exhibited a degree of correlation with each miRNA expression that was greater than would be expected by chance. To identify those genes, the level of significance was chosen to be outside the range of the randomized distribution and above the 99.95% quantile of the experimental distribution for positively correlated genes and below the 0.05% quantile for the negatively correlated genes ( Table 2 ). The most significant positively and negatively correlated genes were identified from the AML microarray expression profile data, with both association measures. (The complete lists of genes and their correlation coefficient values, calculated for miR-181a, miR-10a, miR-10b and miR-196a-1 are reported in Supplementary Tables S5, S6 , S7 and S8, respectively.)
MiR-181a correlates with the expression of its target genes and with the leukaemic morphological sub-type As reported in Table 2 , miR-181a showed the highest number of significantly correlated genes. It is notable that 28 genes among these had been previously proposed, purely on computational predictive grounds, to be targets of miR-181a (Table 3) . [27] [28] [29] 34, 35 The negative correlation showed by 15 of these 28 genes suggests that miR-181a in leukaemic cells may be directly regulating the transcript level of a number of its targets. A more complex model of regulation would be required to explain the MicroRNA correlates with acute leukaemia signature S Debernardi et al positive correlation between miR-181a and the remaining 13 targets.
A hierarchical cluster analysis of the AML samples using the set of genes most significantly correlated with miR-181a, clearly identified a natural grouping of the data based on the morphological FAB phenotype 24 as shown by the dendrogram in Figure 1a . The levels of expression of miRNA-181a, shown in Figure 1b , were elevated in samples with M1 or M2 morphology, compared with the samples with M4 or M5 morphology. By contrast, in normal human BM, miR-181a has been reported to be preferentially expressed in B cells, T cells, monocytes and granulocytes, 32 which are more closely allied to the M4 and M5 morphological leukaemic subtypes. The elevated expression of miR-181a observed here in myeloblastic leukaemias implies its involvement in the leukaemic process.
miR-10a, miR-10b and miR-196a-1 correlate with HOX genes
The expression of the three miRNAs located in intergenic regions in the HOX clusters, miR-10a, miR-10b and miR-196a-1, showed a distinctive correlation with that of the HOX genes in the 30 AMLs. The correlation coefficient values were high and positive for almost all the genes of the HOXA and HOXB clusters, with the exception of HOXA1 and HOXA13 in cluster A and HOXB1 and HOXB13 in cluster B (Supplementary Table  S9 ). By contrast, with the results for human leukaemic tissue presented here, HOXA1 listed among the putative targets for both miR-10a and miR-10b, in the K562 myeloblastic cell line, has been experimentally shown to be down-regulated by ectopic expression of miR-10a. 36 In mouse embryos, it has been shown experimentally that HOXB8 is target for miRNA-196a.
3,4 Both cases underline the specificity of the 
The level of significance was chosen to be outside the range of the randomized distribution, and above the 99.95% quantile of the experimental distribution for positively correlated genes and below the 0.05% quantile for the negatively correlated. Table S9 ). Finding an association in expression levels between miRNAs and HOX gene expression does not necessarily imply a direct causal link. On the contrary, the expression of the miRNAs within the HOX clusters could be affected by the same regulatory elements across paralog clusters. It has been reported that in mouse embryos, the two homologues miR-10a and miR196a seemed to be expressed in patterns that were reminiscent of those of HOX genes, 3 but no reference was made with regard to chromosomal position.
Nearly 30% of the genes showing a high correlation with miRNA-10a, miRNA-10b and miRNA-196a-1 have been shown to have oncogenic potential, in addition to the HOX genes (Supplementary Tables S6, S7 and S8). Positive correlation was found for MEIS1, PBX3, RUNX1 and JUND. The tyrosine kinase oncogene FES 37 and the pro-apoptotic FADD were negatively correlated. The overrepresentation of transcription factors supports a previous hypothesis of oncogene activation driven by elevated level of HOX genes associated with leukaemogenesis.
38,39
Conclusions
This study has established the association of level of miR-181a with specific leukaemic phenotype, suggesting a possible role in the developmental lineage and differentiation state of the tumour. Moreover, it has highlighted the correlation of miR181a level with that of a number of its targets, suggesting the direct regulation at transcript level. This study illustrates the potential for using quantitative measurement of miRNA expression to sub-classify cancer and suggests that a more detailed analysis of a larger numbers of miRNAs could provide valuable insights into the leukaemogenic process. supported by grants from the Kay Kendall Leukaemia Fund and the Barts and London Charitable Foundation.
